Table 2.
MRI(W) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | |||
PTV59 (V100%) | ‐ | 5.3% | ‐ | 3.5% | 2.7% | 3.7% | 5.8% | ||
PTV59 (V93%) | ‐ | 0.0% | ‐ | 0.0% | 0.2% | 2.2% |
|
||
PTV63 (V100%) | 1.7% | 3.6% | 9.9% | 8.3% | 2.3% | 6.5% | 9.8% | ||
PTV63 (V93%) | 0.3% | 0.2% | 1.2% | 1.7% | 0.7% | 1.7% | 0.4% | ||
PTV70 (V100%) | 12.0% | 18.2% | 65.0% | 12.9% | 6.5% | 14.0% | 65.5% | ||
PTV70 (V93%) | 0.0% | 0.1% | 0.1% | 0.0% | 0.8% | 0.9% | 0.1% | ||
|
|||||||||
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | |||
PTV59 (V100%) | ‐ | 1.0% | ‐ |
|
1.7% | 1.8% | 1.6% | ||
PTV59 (V93%) | ‐ | 0.0% | ‐ | 0.0% | 0.1% | 1.6% | 0.2% | ||
PTV63 (V100%) |
|
0.7% | 2.2% | 1.4% | 1.0% | 2.4% | 1.9% | ||
PTV63 (V93%) |
|
0.1% | 0.7% | 1.3% | 0.4% | 1.0% | 0.2% | ||
PTV70 (V100%) |
|
0.9% | 5.7% | 0.4% | 2.5% | 2.2% | 2.6% | ||
PTV70 (V93%) |
|
0.0% |
|
0.0% | 0.6% | 0.5% | 0.0% | ||
|
|||||||||
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | |||
PTV59 (V100%) | ‐ | 1.6% | ‐ |
|
0.3% | 2.6% | 1.7% | ||
PTV59 (V93%) | ‐ | 0.0% | ‐ | 0.0% | 0.0% | 1.6% |
|
||
PTV63 (V100%) | 0.3% |
|
2.9% | 2.0% | 0.8% | 2.0% | 2.6% | ||
PTV63 (V93%) | 0.1% |
|
0.9% | 0.0% |
|
1.3% | 0.3% | ||
PTV70 (V100%) | 1.5% | 1.7% | 7.4% | 3.5% | 4.1% | 3.7% | 2.6% | ||
PTV70 (V93%) |
|
|
0.0% | 0.0% | 0.7% | 0.3% | 0.0% |